Catalyst Wire Dossier Catalyst Wire Dossier

Valcyte (valganciclovir)

valganciclovir · F. Hoffmann-La Roche Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Valcyte (valganciclovir), covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients [Phase 4]

See pricing